Buying GHK-Cu in the USA: the Copper Is Not an Impurity

Describe GHK-Cu as a tripeptide and most of what makes it interesting has already gone missing. The subject of study is a coordination complex. Its copper ion is neither an impurity nor a delivery vehicle bolted onto a peptide; it is a constituent of the molecule under investigation.

The coordination chemistry

GHK is glycyl-L-histidyl-L-lysine. Three nitrogen atoms grip the copper(II) ion: the glycine amino nitrogen, the deprotonated backbone amide nitrogen between glycine and histidine, and the imidazole nitrogen of histidine. The lysine side chain remains free. The resulting geometry is square-planar, or a distortion of it, which is the arrangement a Cu(II) center with a nitrogen donor set normally adopts.

That distortion has a cause worth naming. Copper(II) is a d9 ion and is therefore subject to Jahn–Teller distortion, which is why nobody describes this complex as a clean octahedron. The three GHK nitrogens occupy equatorial positions, while the remaining equatorial site and the weakly held axial positions are filled by water or by whatever else the buffer supplies. That is one direct route by which buffer composition changes the species actually present in a tube.

Why the deprotonated amide is the unusual feature

Protonated amide nitrogens are poor donors. Deprotonation turns a backbone amide into a strong one, and copper coordination itself promotes that deprotonation. Two consequences follow. The complex has a defined formation pH window rather than assembling wherever copper and peptide happen to meet, and acidifying a stock solution does not simply adjust a charge state, it takes the complex apart.

What is in the tube is a population, not a compound

In solution, copper and GHK sit in equilibrium across several forms: free peptide, free hydrated copper, the 1:1 complex, and, at elevated concentrations or non-physiological pH, further stoichiometries including bis-complexes and hydroxide-bridged dimers. Which of these predominates depends on pH, on the copper-to-peptide ratio and on total concentration.

A phrase such as “GHK-Cu at 10 micromolar” therefore names a formulation rather than a molecular species. A study that leaves out pH and stoichiometry has not finished specifying what it tested.

Exchange ligand rather than copper donor

The stability constant for GHK occupies a particular window: strong enough to compete with albumin, the principal copper carrier in plasma, and weak enough that copper can still move in either direction under physiological conditions. A ligand binding copper much more tightly would sequester it; one binding much more weakly would never pick it up at all. That intermediate position is the mechanistic claim being made, and it is a thermodynamic statement rather than a statement about any downstream biology. The indexed literature is at PubMed.

Routine reagents that quietly wreck the experiment

Many more ordinary reagents interfere with this compound than with a plain peptide.

• EDTA, EGTA and DTPA strip the copper outright. Even trace EDTA carried over in a stock buffer is enough to matter, so a medium containing it is not a neutral vehicle here.
• Phosphate buffers can precipitate copper phosphate at higher concentrations, reducing effective copper with no visible sign.
• Reducing agents such as DTT, TCEP, 2-mercaptoethanol and high ascorbate reduce Cu(II) to Cu(I) and destabilize the complex.
• Serum introduces albumin, which competes for the copper. Serum-containing and serum-free assays are measuring different speciation and are not directly comparable.
• Histidine in the medium is itself a copper ligand and joins the exchange equilibrium.
• Acidic stocks. Dilute acetic acid, the reflex default for peptide stocks in most laboratories, dissociates this complex. Near-neutral is the correct starting point.

Redox behavior, and the control arms it forces

Copper cycles between Cu(II) and Cu(I). Introduce a reductant, ascorbate being the usual candidate in culture medium and glutathione the intracellular one, and a copper complex can drive Fenton-type chemistry that produces hydroxyl radicals. Whether a given complex does so depends on how fully its coordination sphere is saturated and on its own redox potential. GHK-Cu is generally reported as comparatively redox-quiet on those grounds, and “comparatively” is carrying weight in that sentence.

The practical consequence is that a copper-complex experiment needs arms that a plain peptide experiment never requires:

• Free peptide alone, to separate a peptide-mediated effect from one that belongs to the complex.
• Copper salt alone at matched copper concentration. This is the arm most often omitted, and the one that most often turns out to explain a striking result.
• An unrelated copper complex, wherever the question is whether an effect is copper-specific or complex-specific.
• A chelator arm, confirming that removing the copper also removes the effect.
• Vehicle at matched pH, since the conditions this complex requires are not the laboratory default.

Without the copper-alone arm, no observed effect can be attributed to the complex rather than to the metal. Much of the older work in this area is difficult to interpret for exactly that reason.

Certifying a complex is not certifying a peptide

Certificates for GHK-Cu are misread constantly, because the number printed on the page may describe either the peptide or the complex, and those are not equivalent quantities.

• RP-HPLC purity is typically run under acidic, TFA-containing conditions that take the complex apart. The resulting figure describes the purity of the GHK peptide component. That is useful, but not sufficient on its own.
• Copper content and stoichiometry need a separate determination: ICP-MS or ICP-OES for total copper, or atomic absorption. A correctly formed complex should give a 1:1 molar ratio of copper to peptide. A marked excess indicates free copper salt in the material; a deficit indicates incomplete complexation.
• UV-visible spectroscopy is the quick confirmation. The Cu(II) d–d transition produces the characteristic blue, with an absorbance maximum around 620–640 nm, and the position of that maximum shifts with the donor set, so the spectrum reports on coordination rather than merely on copper being present somewhere.
• EPR spectroscopy settles the coordination environment definitively when the question justifies the effort, since Cu(II) is paramagnetic.
• Mass spectrometry under gentle, non-acidic ionization can show the intact complex, and the two natural isotopes of copper leave a distinctive pattern confirming that the metal really is part of the observed ion.
• Net peptide content still applies and is more involved than usual, because counterion, copper and residual water all contribute to gross mass.

When comparing certificates across suppliers, establish first whether the quoted figure refers to the peptide or to the complex. Our notes on reading a certificate of analysis, why certificates of analysis disagree on purity and HPLC and mass spectrometry verification set out what these documents do and do not establish.

Handling and storage

• Reconstitute near neutral pH using sterile water or a near-neutral buffer, never dilute acid.
• Watch the color. The solution is distinctly blue, and a loss of that color, or a drift toward green, means the coordination environment has changed. Crude and non-quantitative, but still the fastest in-process check available.
• Avoid metal-chelating plasticware additives, and rinse any glassware that might carry detergent residues containing chelators.
• Store cold and protected from light, aliquoted so that no tube is thawed more than once.
• Do not assume a solution is stable. Speciation drifts. A stock that was correct on day one is not automatically correct at week six. Keep a reference aliquot and re-check by UV-vis, which costs little and takes minutes.

General conditions are covered in storage and stability of lyophilized research peptides, solvent choice in choosing a reconstitution solvent, and record-keeping in keeping a peptide inventory.

Five questions to put to any published study

• Was pH stated, and did it fall inside the range where the complex forms?
• Was copper-to-peptide stoichiometry reported, or only a concentration?
• Did the design include a copper-salt-alone control?
• Was the medium serum-containing, and was albumin competition accounted for?
• Did anyone verify that the complex survived the assay conditions, or was that assumed?

A paper reporting on “GHK-Cu” without answering the first three has characterized a formulation rather than a molecular species, and results of that kind do not compare cleanly with one another.

Glossary

• Coordination complex — a metal ion held by donor atoms from one or more ligands.
• Donor set — the specific atoms coordinating the metal; in this case three nitrogens from GHK.
• Stability constant — equilibrium constant for complex formation, which sets competition against other ligands.
• Speciation — how a metal distributes across every chemical form present under given conditions.
• Jahn–Teller distortion — the geometric distortion characteristic of d9 ions such as Cu(II).
• d–d transition — the electronic transition that gives the complex its visible color.
• Fenton chemistry — a redox-active metal plus a reductant generating hydroxyl radicals.
• ICP-MS — inductively coupled plasma mass spectrometry, the reference method for elemental copper quantitation.

Products: GHK-Cu 50mg, GHK-Cu 100mg, and the broader copper peptides category.

ExoLabz supplies compounds for laboratory research use only. Nothing on this page is medical advice or a suggestion of human or veterinary use.